Investing in the Future of Precision Cancer Medicine

Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas
and solid tumor cancers

Trovagene Business Update
 June 7, 2019 -
September 7, 2019
 8:00am PDT

Trovagene will be conducting a Company Business Update conference call and webcast on Friday, June 7th, 2019 at 11:00 am EDT (8:00 am PDT). The dial-in number is (866) 792-4365 [International Dial-In: (270) 215-9475]. The conference ID is 859614 and the webcast URL is The webcast will be archived and available following the call for 90 days.